Amina Nadeem (11 results)

Paperback. Condition: New. Interferon Alpha and Ribavirin Induced Thyroid Dysfunction: In Patients with Chronic Hepatitis C Brand new item sourced directly from publisher. Packed securely in tight packaging to ensure no damage. Shipped from warehouse on same/next day basis.

Condition: New. In.

Paperback. Condition: New.

Taschenbuch. Condition: Neu. Interferon Alpha and Ribavirin Induced Thyroid Dysfunction | In Patients with Chronic Hepatitis C | Amina Nadeem (u. a.) | Taschenbuch | 160 S. | Englisch | 2012 | LAP LAMBERT Academic Publishing | EAN 9783847375135 | Verantwortliche Person für die EU: OmniScriptum GmbH & Co. KG, Bahnhofstr. 28, 66111 Saarbrücken, info[at]akademikerverlag[dot]de | Anbieter: preigu.

Paperback. Condition: Like New. Like New. book.

PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -According to WHO studies, approximately 170 million individuals of the world population are diagnosed to be infected with Hepatitis C virus. Unfortunately around 20 % of these patients experience progressive liver disease leading to cirrhosis or hepatocellular carcinoma over 20 to 40 years. Interferon-alpha and ribavirin combination therapy is the standard treatment for chronic hepatitis C. These drugs may trigger production of different types of non-specific and specific autoantibodies. Thyroid dysfunction, which has been reported to occur from 3.9-33.33%, is the most common autoimmune disorder associated with combination therapy. Therefore, it is necessary that thyroid functions are monitored during therapy and the course of thyroid disease is watched for once autoimmune thyroid disorder develops. This book highlights the effects of Interferon and ribavirin on thyroid functions, its pathogenesis, clinical features and outcome through a cohort study carried out on chronic hepatitis C patients. 160 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Nadeem AminaDr. Amina Nadeem, (MBBS,FCPS,PhD scholar)is working as Assistant Professor of Physiology at Army Medical College, National University of Sciences and Technology, Pakistan. She is passionately involved in teaching human Ph.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -According to WHO studies, approximately 170 million individuals of the world population are diagnosed to be infected with Hepatitis C virus. Unfortunately around 20 % of these patients experience progressive liver disease leading to cirrhosis or hepatocellular carcinoma over 20 to 40 years. Interferon-alpha and ribavirin combination therapy is the standard treatment for chronic hepatitis C. These drugs may trigger production of different types of non-specific and specific autoantibodies. Thyroid dysfunction, which has been reported to occur from 3.9-33.33%, is the most common autoimmune disorder associated with combination therapy. Therefore, it is necessary that thyroid functions are monitored during therapy and the course of thyroid disease is watched for once autoimmune thyroid disorder develops. This book highlights the effects of Interferon and ribavirin on thyroid functions, its pathogenesis, clinical features and outcome through a cohort study carried out on chronic hepatitis C patients.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 160 pp. Englisch.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - According to WHO studies, approximately 170 million individuals of the world population are diagnosed to be infected with Hepatitis C virus. Unfortunately around 20 % of these patients experience progressive liver disease leading to cirrhosis or hepatocellular carcinoma over 20 to 40 years. Interferon-alpha and ribavirin combination therapy is the standard treatment for chronic hepatitis C. These drugs may trigger production of different types of non-specific and specific autoantibodies. Thyroid dysfunction, which has been reported to occur from 3.9-33.33%, is the most common autoimmune disorder associated with combination therapy. Therefore, it is necessary that thyroid functions are monitored during therapy and the course of thyroid disease is watched for once autoimmune thyroid disorder develops. This book highlights the effects of Interferon and ribavirin on thyroid functions, its pathogenesis, clinical features and outcome through a cohort study carried out on chronic hepatitis C patients.